U.K. drug maker agrees to buy Transkaryotic

Article Abstract:

Shire Pharmaceuticals Group PLC of the United Kingdom is to acquire Transkaryotic Therapies Inc. of the United States for $1.6 billion. Chief Executive Officer of Transkaryotic Therapies Inc., Michael Astrue has resigned in apparent disagreement with the acquisition. Transkaryotic Therapies Inc., a biotechnology company, shares are up 16 percent to $35.21 on the Nasdaq Stock Exchange.

Commodity & service prices, Securities issued, listed, Security brokers and dealers, Securities & Commodities Services, Securities, Commodity Contracts, and Other Financial Investments and Related Activities, Prices and rates, Securities industry, Securities, Company securities, Company pricing policy

---

Hedge Funds vex a Shire takeover of Transkaryotic

Article Abstract:

Shire Pharmaceuticals Group PLC of the United Kingdom is to acquire Transkaryotic Therapies Inc. of the United States for $1.6 billion. One third of Transkaryotic Therapies Inc.'s shareholders want their shares appraised, which could raise the price of the acquisition for Shire Pharmaceuticals Group PLC.

Financial management, Investor relations

---

Marconi will link ipsaris with Easynet in stock deal

Article Abstract:

Marconi PLC will merge its ipsaris Ltd. subsidiary with Easynet Group PLC. The newly-merged entity will provide broadband services.

Telecommunications, Telegraph & other communications, Telephone Communication, Planning, Internet service providers, Telecommunications industry, Broadband transmission, Broadband, Telent PLC, Ipsaris, Easynet Group PLC

Similar abstracts:

• Abstracts: In Asia funds, smaller was beautiful. Hedge funds try to lose their villainous reputation. Firm takes aim at Australia
• Abstracts: HBC merges retail loyalty programs. Banks ads pledge customer care. Turning the page
• Abstracts: U.S. steel tariffs may continue. Geneva Steel shuts most operations, lays off many staff. USX decides to separate U.S. Steel, Marathon Oil
• Abstracts: Diageo may be bitter for short-term buyers. De Beers holders approve Oppenheimer-led buyout. ThyssenKrupp reaches deal for unit of Magneti Marelli
• Abstracts: Denmark:Thrane & Thrane reach agreement with Nera. Denmark: Thrane & Thrane's interim report. DENMARK: THRANE & THRANE AWARDED DKR360MN CONTRACT

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.